On the mineralocorticoid and hypertensogenic properties of 16 β-Hydroxy-Dehydroepiandrosterone

C. Gomez-Sanchez, O. B. Holland, C. E. Hall, S. Ayachi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Dosages of either 1 or 2 mg daily of 16β-hydroxy-dehydroepiandrosterone, given to mononephretomized, salt-loaded female rats, had no detectable effect upon saline consumption, blood pressure, kallikrein excretion or heart and kidney weight. Its alleged mineralocorticoid properties, as judged by these criteria, were not demonstrable.

Original languageEnglish (US)
Pages (from-to)1067-1069
Number of pages3
JournalExperientia
Volume32
Issue number8
DOIs
StatePublished - Aug 1976

Fingerprint

Mineralocorticoids
Kallikreins
Dehydroepiandrosterone
Blood pressure
Rats
Salts
Blood Pressure
Kidney
Weights and Measures

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

On the mineralocorticoid and hypertensogenic properties of 16 β-Hydroxy-Dehydroepiandrosterone. / Gomez-Sanchez, C.; Holland, O. B.; Hall, C. E.; Ayachi, S.

In: Experientia, Vol. 32, No. 8, 08.1976, p. 1067-1069.

Research output: Contribution to journalArticle

Gomez-Sanchez, C, Holland, OB, Hall, CE & Ayachi, S 1976, 'On the mineralocorticoid and hypertensogenic properties of 16 β-Hydroxy-Dehydroepiandrosterone', Experientia, vol. 32, no. 8, pp. 1067-1069. https://doi.org/10.1007/BF01933976
Gomez-Sanchez, C. ; Holland, O. B. ; Hall, C. E. ; Ayachi, S. / On the mineralocorticoid and hypertensogenic properties of 16 β-Hydroxy-Dehydroepiandrosterone. In: Experientia. 1976 ; Vol. 32, No. 8. pp. 1067-1069.
@article{b03f946ab19a4ab2b17f25a95586c9e4,
title = "On the mineralocorticoid and hypertensogenic properties of 16 β-Hydroxy-Dehydroepiandrosterone",
abstract = "Dosages of either 1 or 2 mg daily of 16β-hydroxy-dehydroepiandrosterone, given to mononephretomized, salt-loaded female rats, had no detectable effect upon saline consumption, blood pressure, kallikrein excretion or heart and kidney weight. Its alleged mineralocorticoid properties, as judged by these criteria, were not demonstrable.",
author = "C. Gomez-Sanchez and Holland, {O. B.} and Hall, {C. E.} and S. Ayachi",
year = "1976",
month = "8",
doi = "10.1007/BF01933976",
language = "English (US)",
volume = "32",
pages = "1067--1069",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "8",

}

TY - JOUR

T1 - On the mineralocorticoid and hypertensogenic properties of 16 β-Hydroxy-Dehydroepiandrosterone

AU - Gomez-Sanchez, C.

AU - Holland, O. B.

AU - Hall, C. E.

AU - Ayachi, S.

PY - 1976/8

Y1 - 1976/8

N2 - Dosages of either 1 or 2 mg daily of 16β-hydroxy-dehydroepiandrosterone, given to mononephretomized, salt-loaded female rats, had no detectable effect upon saline consumption, blood pressure, kallikrein excretion or heart and kidney weight. Its alleged mineralocorticoid properties, as judged by these criteria, were not demonstrable.

AB - Dosages of either 1 or 2 mg daily of 16β-hydroxy-dehydroepiandrosterone, given to mononephretomized, salt-loaded female rats, had no detectable effect upon saline consumption, blood pressure, kallikrein excretion or heart and kidney weight. Its alleged mineralocorticoid properties, as judged by these criteria, were not demonstrable.

UR - http://www.scopus.com/inward/record.url?scp=0017157070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017157070&partnerID=8YFLogxK

U2 - 10.1007/BF01933976

DO - 10.1007/BF01933976

M3 - Article

VL - 32

SP - 1067

EP - 1069

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 8

ER -